Delix Therapeutics logo

Delix Therapeutics jobs and careers

Boston, MA, United States

About Delix Therapeutics

Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Founded in 2019 by David E. Olson and Nick Haft.

Founded
2019
Employees
1 to 10
Total funding
$119.1M
Headquarters
Boston

Leadership

The top of Delix Therapeutics's org chart, with how many people report into each leader.

MRPhoto of Mark Rus

Mark Rus

CEO

12 reports

ESPhoto of Eliseo Salinas

Eliseo Salinas

Head of Research And Development

5 reports

DOPhoto of David Olson

David Olson

Chief Innovation Officer and Head of the Scientific Advisory Board

2 reports

RMPhoto of Retsina Meyer

Retsina Meyer

Head of Corporate Strategy

MGPhoto of Matt Gorman

Matt Gorman

CFO

TMPhoto of Tricia Mccall

Tricia Mccall

Chief People Officer (CPO)

Board

NH

Nick Haft

Director

JKPhoto of John Krystal

John Krystal

Advisor

FWPhoto of Florence Wagner

Florence Wagner

Advisor

CLPhoto of Craig Lindsley

Craig Lindsley

Advisor

CLPhoto of Conor Liston

Conor Liston

Advisor

JHPhoto of Jacob Hooker

Jacob Hooker

Advisor

Jobs at Delix Therapeutics

No open positions right now. Explore more companies on TheJobsMap.